DNLI position history
The shares of Denali Therapeutics (DNLI) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 26,900 shares, $444K, <0.01% of portfolio, New
- 2026 Q1: 65,301 shares, $1.3M, <0.01% of portfolio, Add +142.8%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|